.Attribute Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective calls for introduction of patients with MASLD as well as dimension of liver results in cardio-- renal-- metabolic tests, when data advise mechanistically probable advantages and medical security-- and describes considerations for trial style and regulatory commendation.